References
- Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N. Engl. J. Med. 343(13), 938–952 (2000).
- Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat. Rev. Immunol. 8(9), 685–698 (2008).
- Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 9(7), 727–739 (2010).
- Summerday NM, Brown SJ, Allington DR, Rivey MP. Vitamin D and multiple sclerosis: review of a possible association. J. Pharm. Pract. 25(1), 75–84 (2012).
- Mowry EM, Waubant E, McCulloch CE et al. Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis. Ann. Neurol. 72(2), 234–240 (2012).
- Besler HT, Comoglu S, Okçu Z. Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr. Neurosci. 5(3), 215–220 (2002).
- Royal W 3rd, Gartner S, Gajewski CD. Retinol measurements and retinoid receptor gene expression in patients with multiple sclerosis. Mult. Scler. 8(6), 452–458 (2002).
- Løken-Amsrud KI, Myhr KM, Bakke SJ et al. Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis. Mult. Scler. doi:10.1177/1352458512457843 (2012) (Epub ahead of print).
- Torkildsen O, Wergeland S, Bakke S et al. ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial. Arch. Neurol. 69(8), 1044–1051 (2012).
- Ramagopalan SV, Maugeri NJ, Handunnetthi L et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 5(2), e1000369 (2009).
- Filippi M, Rocca MA, De Stefano N et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch. Neurol. 68(12), 1514–1520 (2011).
- Barkhof F, Simon JH, Fazekas F et al. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat. Rev. Neurol. 8(1), 13–21 (2012).
- Filippi M, Rocca MA. MR imaging of multiple sclerosis. Radiology 259(3), 659–681 (2011).
- Qu ZX, Dayal A, Jensen MA, Arnason BG. All-trans retinoic acid potentiates the ability of interferon β-1b to augment suppressor cell function in multiple sclerosis. Arch. Neurol. 55(3), 315–321 (1998).
- Qu ZX, Pliskin N, Jensen MW, White D, Arnason BG. Etretinate augments interferon β-1b effects on suppressor cells in multiple sclerosis. Arch. Neurol. 58(1), 87–90 (2001).